Hannay Michael Charles Ferguson sold $8K of BCYC
Hannay Michael Charles Ferguson (CHIEF PROD & SUPPLY CHAIN OFF) sold 1,761 shares of BICYCLE THERAPEUTICS PLC (BCYC) at an average of $4.28 ($4.27–$4.31) across 2 trades over 2026-07-02 to 2026-07-06.
How this was made
The 30-second read
Why it matters
This provides a new, primary-source datapoint on insider selling activity (open-market sale) but does not include any operational, clinical, regulatory, or financial guidance changes.
Market read
Traders may note the insider sale for sentiment monitoring, but the disclosed value (~$7.5k) is unlikely to drive price action absent other catalysts.
What to watch
No 10b5-1 plan is cited, but the filing does not provide intent; without follow-on buys/sells or performance-linked context, signal quality is limited.
Background
The article is an SEC Form 4 insider transaction disclosure for Bicycle Therapeutics PLC (BCYC).
Ticker impact
Bicycle Therapeutics PLC insider Form 4 shows officer Hannay Ferguson sold 1,761 shares in open-market trades at ~$4.27–$4.31.
Low likelihood of a sustained price move; any reaction is likely brief and sentiment-driven.
Form 4 insider sales are common and the disclosed transaction size ($7.5k) is small relative to typical market impact, with no accompanying operational or guidance catalyst.
Market effects
Minimal; this is an issuer-specific insider transaction with no sector-wide signal provided.
None indicated.
None indicated.
Counterpoint
The sale could be for diversification/tax or routine liquidity needs rather than a bearish view, especially given the small dollar amount.
Key entities
- issuerBicycle Therapeutics PLC
Subject of the Form 4 insider transaction disclosure.
- insiderHannay Michael Charles Ferguson
Chief Product & Supply Chain Officer who sold shares.